Binding of [ 3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-( m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes — a new, selective antagonist radioligand for A 2A adenosine receptors

Abstract

The present study describes the preparation and binding properties of a new, potent, and selective A 2A adenosine receptor (AR) antagonist radioligand, [ 3H]3-(3-hydroxypropyl)-7-methyl-8-( m-methoxystyryl)-1-propargylxanthine ([ 3H]MSX-2). [ 3H]MSX-2 binding to rat striatal membranes was saturable and reversible. Saturation experiments showed that [ 3H]MSX-2 labeled a single class of binding sites with high affinity ( K d =8.0 nM) and limited capacity ( B max =1.16 fmol·mg −1 of protein). The presence of 100 μM GTP, or 10 mM magnesium chloride, respectively, had no effect on [ 3H]MSX-2 binding. AR agonists competed with the binding of 1 nM [ 3H]MSX-2 with the following order of potency: 5′- N-ethylcarboxamidoadenosine (NECA)>2-[4-(carboxyethyl)phenylethylamino]-5′- N-ethylcarboxamidoadenosine (CGS-21680)>2-chloroadenosine (2-CADO)> N 6-cyclopentyladenosine (CPA). AR antagonists showed the following order of potency: 8-( m-bromostyryl)-3,7-dimethyl-1-propargylxanthine (BS-DMPX)>1,3-dipropyl-8-cyclopentylxanthine (DPCPX)>( R)-5,6-dimethyl-7-(1-phenylethyl)-2-(4-pyridyl)-7 H-pyrrolo[2,3- d]pyrimidine-4-amine (SH-128)>3,7-dimethyl-1-propargylxanthine (DMPX)>caffeine. The K i values for antagonists were in accordance with data from binding studies with the agonist radioligand [ 3H]CGS21680, while agonist affinities were 3–7-fold lower. [ 3H]MSX-2 is a highly selective A 2A AR antagonist radioligand exhibiting a selectivity of at least two orders of magnitude versus all other AR subtypes. The new radioligand shows high specific radioactivity (85 Ci/mmol, 3150 GBq/mmol) and acceptable nonspecific binding at rat striatal membranes of 20–30%, at 1 nM.